Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by TruPharma LLC, priced at $0.0211 per EA under NDC 52817033010. Its NADAC has been published 421 times since Jun 6, 2018.
Strength
5 mg/1
Manufacturer
TruPharma LLCNDC
52817033010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208170On Market Since
5/31/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 421 times since Jun 6, 2018, and over the history we have for it it has declined 42.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0211 per EA |
|---|---|
| All-time high | $0.0368 (Jun 13, 2018) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0220 |
| 52-week low | $0.0209 |
| Median price | $0.0278 |
| Average price | $0.0276 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 421 |
| Tracking since | Jun 6, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by TruPharma LLC, is $0.0211 per EA (NDC 52817033010), effective Jun 24, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 42.7%. It has been tracked across 421 weekly CMS publications since Jun 6, 2018.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Jun 6, 2018, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0368 (Jun 13, 2018), with a median of $0.0278 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CYCLOBENZAPRINE 5 MG TABLET, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 52817033010) is labeled by TruPharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification